145 related articles for article (PubMed ID: 7104552)
1. Plasma lithium levels and therapeutic outcome in the prophylaxis of affective disorders: a retrospective study.
Sashidharan SP; McGuire RJ; Glen AI
Br J Psychiatry; 1982 Jun; 140():619-22. PubMed ID: 7104552
[TBL] [Abstract][Full Text] [Related]
2. Outcome of lithium prophylaxis: a prospective follow-up of affective disorder patients assigned to high and low serum lithium levels.
Vestergaard P; Licht RW; Brodersen A; Rasmussen NA; Christensen H; Arngrim T; Grønvall B; Kristensen E; Poulstrup I
Acta Psychiatr Scand; 1998 Oct; 98(4):310-5. PubMed ID: 9821453
[TBL] [Abstract][Full Text] [Related]
3. Cell membrane predictors of response to lithium prophylaxis of affective disorders.
Del Vecchio M; Farzati B; Maj M; Minucci P; Guida L; Kemali D
Neuropsychobiology; 1981; 7(5):243-7. PubMed ID: 7312143
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of the erythro-plasmatic ratio of lithium (author's transl)].
Braccini T; Darcourt G; Corti H; Lapalus P; Lavagna J; Myquel M
Acta Psychiatr Belg; 1980; 80(4):413-9. PubMed ID: 6116378
[TBL] [Abstract][Full Text] [Related]
5. Long-term effect of lithium maintenance therapy on estimated glomerular filtration rate in patients with affective disorders: a population-based cohort study.
Clos S; Rauchhaus P; Severn A; Cochrane L; Donnan PT
Lancet Psychiatry; 2015 Dec; 2(12):1075-83. PubMed ID: 26453408
[TBL] [Abstract][Full Text] [Related]
6. Cognitive and affective functions in patients with affective disorders treated with lithium. An assessment by questionnaire.
Kjellman BF; Karlberg BE; Thorell LH
Acta Psychiatr Scand; 1980 Jul; 62(1):32-46. PubMed ID: 7446191
[TBL] [Abstract][Full Text] [Related]
7. Relationship between prophylactic effect of lithium therapy and family history of affective disorders.
Engström C; Aström M; Nordqvist-Karlsson B; Adolfsson R; Nylander PO
Biol Psychiatry; 1997 Sep; 42(6):425-33. PubMed ID: 9285078
[TBL] [Abstract][Full Text] [Related]
8. Serum drug level monitoring in affective disorders.
Krska J; Corner DA
J Clin Pharm Ther; 1992 Dec; 17(6):357-63. PubMed ID: 1287028
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell plasma Li ratio variability in affective patients.
Catalano M; Gasperini M; Lucca A; Brancato V; Smeraldi E
Neuropsychobiology; 1987; 18(1):5-8. PubMed ID: 3444525
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the lithium RBC/plasma ratio as a predictor of the prophylactic effect of lithium treatment in affective disorders.
Knorring L; Oreland L; Perris C; Wiberg A
Pharmakopsychiatr Neuropsychopharmakol; 1976 Mar; 9(2):81-4. PubMed ID: 981325
[TBL] [Abstract][Full Text] [Related]
11. [The lithium concentration of the blood plasma in combined therapy with lithium carbonate and carbamazepine].
Skorik AI
Farmakol Toksikol; 1991; 54(4):57-9. PubMed ID: 1786831
[TBL] [Abstract][Full Text] [Related]
12. The utility of a single-point dosing protocol for predicting steady-state lithium levels.
Perry PJ; Alexander B; Prince RA; Dunner FJ
Br J Psychiatry; 1986 Apr; 148():401-5. PubMed ID: 3089352
[TBL] [Abstract][Full Text] [Related]
13. 5-HT uptake in platelets of lithium-treated patients with affective disorders and of healthy controls.
Thies-Flechtner K; Weigel I; Müller-Oerlinghausen B
Pharmacopsychiatry; 1994 Jul; 27 Suppl 1():4-6. PubMed ID: 7984700
[TBL] [Abstract][Full Text] [Related]
14. Saliva lithium: a poor predictor of plasma and erythrocyte levels.
McKeage MJ; Maling TJ
N Z Med J; 1989 Oct; 102(878):559-60. PubMed ID: 2812583
[TBL] [Abstract][Full Text] [Related]
15. [Labial herpes in patients with affective disorders receiving long-term lithium carbonate].
Rybakowski J; Strzyzewski W; Zelechowska-Ruda E; Chłopocka-Woźniak M
Pol Tyg Lek; 1993 Mar 1-8; 48(9-10):215-7. PubMed ID: 8234051
[TBL] [Abstract][Full Text] [Related]
16. Who responds to prophylactic lithium therapy?
Abou-Saleh MT
Br J Psychiatry Suppl; 1993 Sep; (21):20-6. PubMed ID: 8217063
[TBL] [Abstract][Full Text] [Related]
17. Lithium and electrolytes plasma/RBC ratio and paradoxical lithium neurotoxicity.
Elizur A; Yeret A; Segal Z; Graff E
Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):235-41. PubMed ID: 6890699
[TBL] [Abstract][Full Text] [Related]
18. RBC-choline: a biological marker of the outcome of lithium prophylaxis?
Haag M; Granzow L; Greil W; Haag H
Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):209-12. PubMed ID: 2888160
[TBL] [Abstract][Full Text] [Related]
19. Carbamazepine as adjunct or alternative to lithium in the prophylaxis of recurrent affective disorders.
Fritze J; Beneke M; Lanczik M; Schneider B; Walden J
Pharmacopsychiatry; 1994 Sep; 27(5):181-5. PubMed ID: 7838887
[TBL] [Abstract][Full Text] [Related]
20. Effect of fasting during Ramadan on serum lithium level and mental state in bipolar affective disorder.
Farooq S; Nazar Z; Akhtar J; Irfan M; Subhan F; Ahmed Z; Khan EH; Naeem F
Int Clin Psychopharmacol; 2010 Nov; 25(6):323-7. PubMed ID: 20827213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
